Neurology
Conference Coverage
Hippocampal sparing temporal lobectomy recommended for medically refractory epilepsy
BALTIMORE – Hippocampal sparing anterior temporal lobectomy reduced the risk of memory impairment in patients with intractable temporal lobe...
News
Medicaid spending on MS drugs rose despite introduction of generic glatiramer
“Although some of this increase is attributable to the 2014 Medicaid expansion, the primary driver was rising DMT costs per prescription, which...
News
FDA committee rejects oxycodegol, new opioid designed for less abuse
A novel opioid molecule designed to have less abuse potential with slower CNS entry received a unanimous FDA committee turn down.
Conference Coverage
Comorbidity rates remain stable over 10 years in childhood-onset epilepsy
BALTIMORE – Patients with epilepsy are at higher risk of psychiatric comorbidity than are controls, and the rate of...
News
Half of SLE patients have incident neuropsychiatric events
Average 8-year follow-up of an international lupus inception cohort showed that 52% developed a neuropsychiatric event.
Latest News
FDA Awards Grant To Study Temozolomide in Gist
Conference Coverage
EEG surveillance, preseizure treatment prevents TSC epilepsy, cognitive loss
BALTIMORE – “If you are not convinced to do early treatment,” at least “do surveillance with EEG. You will diagnose epilepsy earlier, and treat...
News
Experts call to revise the Uniform Determination of Death Act
A neurologist and her colleagues propose changes with the goal of clarifying and harmonizing procedures for determining death by neurologic...
FDA/CDC
FDA okays ubrogepant for acute migraine treatment
ACHIEVE I and ACHIEVE II demonstrate efficacy.
Conference Coverage
California researchers work to update EMS status epilepticus protocols
BALTIMORE – There was a lower risk of intubation with 5 mg midazolam IM or more.